Testing effectiveness (Phase 2)Study completedNCT00596804
What this trial is testing
Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma
Who this might be right for
Non-Hodgkin's LymphomaLymphoma, DiffuseLymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Gilead Sciences 39